主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ADIL
#3984
Adial Pharmaceuticals, Inc
2.5
3
+3.27%
版块:
基础:
利润货币:
日范围
年范围
日变化
+3.27%
每月变动
+1000.00%
6个月变化
+548.72%
年变化
+232.89%
前一天收盘价
2.4
5
Open
2.5
3
Bid
Ask
Low
2.5
3
High
2.5
3
交易量
1
市场
股票
医疗保健
ADIL
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
256.23 K
262.98 K
316.03 K
873.13 K
959.5 K
—
Valuation ratios
Enterprise value
-4.95 M
-3.48 M
-2.17 M
-5.65 M
-4.27 M
-15.57 M
Price to earnings ratio
-0.01
-0.01
-0.03
-0.03
-0.09
-0.16
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
-0.02
-0.03
-0.02
-0.01
-0.02
-0.07
Price to book ratio
0.01
0.05
0.01
0
0.01
0.07
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.33
-0.41
-0.65
-0.29
-0.32
-1.66
Return on equity %
-0.37
-0.51
-1.05
-0.35
-0.4
-2.31
Return on invested capital %
-786.5
-650.24
—
—
—
—
Gross margin %
—
—
100
—
—
—
Operating margin %
—
—
-1 511.53
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
-1 485.87
—
—
—
Liquidity ratios
Quick ratio
—
3.69
—
—
—
—
Current ratio
6.78
4.16
1.99
5.02
4.34
15.51
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
—
0.04
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-7.26
-7.49
-6.06
-4.12
-2.07
-19.74
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
22.3
19.33
9.04
13.92
5.19
47.49
Net current asset value per share
24.07
20.92
10.05
14.31
5.65
50.93
Tangible book value per share
25.19
20.95
8.12
13.15
5.08
47.29
Working capital per share
20.52
15.89
4.99
11.46
4.35
36.68
Book value per share
25.21
20.96
8.13
13.16
5.08
47.33
新闻
FDA政策转变推动Adial Pharmaceuticals股价上涨
Adial Pharmaceuticals stock rises on FDA policy shift
Adial Pharmaceuticals寻求通过单一关键性试验推进AD04项目
Adial Pharmaceuticals eyes single pivotal trial path for AD04
Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories! - TipRanks.com
Adial制药公司宣布1比25反向拆股后股价暴跌
Adial Pharmaceuticals stock tumbles after announcing 1-for-25 reverse split
Adial制药公司宣布1比25反向拆股
Adial Pharmaceuticals announces 1-for-25 reverse stock split
Adial制药公司宣布董事会成员James W. Newman, Jr.辞职
Adial Pharmaceuticals announces resignation of board member James W. Newman, Jr.
Has Acurx Pharmaceuticals (ACXP) Outpaced Other Medical Stocks This Year?